AHG Announces Initiation of World-Class, Proprietary Brain-Computer Interface R&D Program - Targeting the Next Frontier of Human Neurotechnology
QINGDAO, China , April 27, 2026 /PRNewswire/ --Â Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generatio n, proprietary Brain-Computer...
Akso Health Group Announces Launch of Exploratory Global Patient Support Initiative
QINGDAO, China , Feb. 3, 2026 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the launch of the an exploratory patient support program and a strategic...
Akso Health Group Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
/PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" the "Company" or "we"), today announced that the Company has received a written notification...
Akso Health Group Receives Notice of Filing Delinquency From Nasdaq
/PRNewswire/ -- Akso Health Group. (NASDAQ: AHG) ("Akso Health" the "Company" or "we"), today announced that the Company received a written notification (the...